Skip to main content
Back to OrbiMed

OrbiMed's Biotechnology Portfolio

Browse 74 Biotechnology companies funded by OrbiMed. See funding amounts, founder contacts, and investment details.

Biotechnology Companies
74
Total Funding in Biotechnology
$6.8B

Biotechnology Portfolio Companies (74)

Export
BiotechnologyHealth CareMedicalTherapeutics

Q32 Bio is a biotechnology company that develops treatments for patients with severe autoimmune and inflammatory diseases.

Cambridge, United States
May 2026
Post-IPO Equity

Founder Contacts

19,000+ verified contacts

BiopharmaBiotechnologyLife ScienceOncology

Whitehawk Therapeutics, a clinical-stage oncology therapeutics firm, applies cutting-edge technologies to well-established tumor biology.

Pacific Palisades, United States
May 2026
Post-IPO Equity

Founder Contacts

19,000+ verified contacts

BiotechnologyLife ScienceTherapeutics

Sidewinder Therapeutics is a biotechnology company that offers life-saving therapies for cancer and rare diseases.

San Diego, United States
April 2026
Series B

Founder Contacts

19,000+ verified contacts

BiotechnologyHealth CareHealth DiagnosticsMedical

Adela creates develops technologies centered around detecting high-risk conditions like cancer through routine blood tests.

Foster City, United States
April 2026
$48.0M
Convertible Note

Founder Contacts

19,000+ verified contacts

BiopharmaBiotechnologyPharmaceuticalTherapeutics

Prelude Therapeutics designs and develops small molecule therapies targeting key drivers of cancer cell growth and resistance.

Wilmington, United States
April 2026
Post-IPO Equity

Founder Contacts

19,000+ verified contacts

Biotechnology

Terremoto Biosciences is a biotechnology company leveraging the power of lysine-based covalency to develop optimized medicines.

San Francisco, United States
April 2026
Series C

Founder Contacts

19,000+ verified contacts

BiopharmaBiotechnologyHealth Care

ImageneBio is dedicated to developing therapeutics for patients with immunological, autoimmune and inflammatory diseases

San Diego, United States
April 2026
Post-IPO Equity

Founder Contacts

19,000+ verified contacts

BiopharmaBiotechnologyPharmaceuticalTherapeutics

Sparrow Pharmaceuticals is a clinical-stage biopharmaceutical company developing treatments for disorders of corticosteroid excess.

Portland, United States
September 2025
$95.0M
Series B

Founder Contacts

19,000+ verified contacts

BiotechnologyHealth CareMedicalOncologyTherapeutics

Avenzo Therapeutics specializes in the development of oncology therapies for cancer treatment.

San Diego, United States
September 2025
$60.0M
Series B

Founder Contacts

19,000+ verified contacts

BiotechnologyHealth CareLife ScienceMedicalPrecision Medicine

Treeline Biosciences is a biotech company building transformative precision medicines for patients with cancer and other serious conditions.

Watertown, United States
September 2025
$200.0M
Series A

Founder Contacts

19,000+ verified contacts

BiopharmaBiotechnologyMedical

ENYO Pharma is a biopharmaceutical company based in Lyon, France.

Lyon, France
June 2025
$6.9M
Series C

Founder Contacts

19,000+ verified contacts

BiotechnologyHealth CareHealth DiagnosticsMedical

Alpheus Medical provides a novel sonodynamic therapy platform targeting solid body cancers.

Oakdale, United States
May 2025
$52.0M
Series B

Founder Contacts

19,000+ verified contacts

BiotechnologyHealth CareHealth DiagnosticsMedicalOncology

Fore Biotherapeutics is a precision oncology company specializing in cancer therapies guided by functional genomics.

Philadelphia, United States
May 2025
$38.0M
Series D

Founder Contacts

19,000+ verified contacts

BiotechnologyMedical

RayThera is dedicated to developing small molecule therapies specifically targeting unmet needs in immunology.

San Diego, United States
April 2025
$110.0M
Series A

Founder Contacts

19,000+ verified contacts

BiotechnologyHealth CareLife ScienceTherapeutics

Garuda Therapeutics develops off-the-shelf hematopoietic stem cell therapies to treat severe and life-threatening diseases.

Cambridge, United States
March 2025
$50.0M
Series A

Founder Contacts

19,000+ verified contacts

BiotechnologyHealth CareMedicalTherapeutics

Aer Therapeutics, a clinical-stage biopharmaceutical company developing therapeutic solutions for muco-obstructive lung diseases.

Raleigh, United States
February 2025
$5.0M
Venture - Series Unknown

Founder Contacts

19,000+ verified contacts

BiopharmaBiotechnologyHealth CareMedicalTherapeutics

Helicore Biopharma is a biopharmaceutical company that discovers and develops novel weight-loss therapeutics.

San Mateo, United States
January 2025
$65.0M
Series A

Founder Contacts

19,000+ verified contacts

BiotechnologyHealth CareMedicalTherapeutics

Triveni Bio is a a biotech company that develops functional antibodies targeting immunological and inflammatory disorders.

Watertown, United States
October 2024
$115.0M
Series B

Founder Contacts

19,000+ verified contacts

BiotechnologyHealth CareTherapeutics

MBX Biosciences is a preclinical-stage biotech company that creates therapies to treat rare endocrine diseases.

Carmel, United States
August 2024
$63.5M
Series C

Founder Contacts

19,000+ verified contacts

BiotechnologyHealth CareMedical

Vanqua Bio is a biotechnology company that discovers and develops next-generation medicines for patients with neurodegenerative diseases.

Chicago, United States
July 2024
$45.0M
Venture - Series Unknown

Founder Contacts

19,000+ verified contacts

BiopharmaBiotechnologyPharmaceutical

Alterome Therapeutics is a biopharmaceutical company developing alteration-specific targeted therapies.

San Diego, United States
April 2024
$132.0M
Series B

Founder Contacts

19,000+ verified contacts

BiotechnologyOncologyTherapeutics

ProfoundBio is a developer of targeted therapeutics intended for patients with cancer.

Seattle, United States
February 2024
$112.0M
Series B

Founder Contacts

19,000+ verified contacts

BiotechnologyHealth CareOncologyPharmaceuticalProduct Research

OnCusp Therapeutics is a biopharmaceutical company turning cutting-edge research assets into innovative oncology treatments.

New York, United States
January 2024
$100.0M
Series A

Founder Contacts

19,000+ verified contacts

BiotechnologyHealth CareInternetPharmaceutical

Koya Medical is a transformative healthcare company developing breakthrough treatments for lymphedema and venous diseases.

Oakland, United States
November 2023
$30.0M
Series C

Founder Contacts

19,000+ verified contacts

BiopharmaBiotechnologyMedicalTherapeutics

Rampart Bioscience develops gene medicines to provide long-lasting treatments for a wide range of diseases.

La Jolla, United States
October 2023
$85.0M
Series A

Founder Contacts

19,000+ verified contacts

BiotechnologyHealth CareLife ScienceMedicalWellness

Minervax is a biotechnology company developing a novel vaccine against Group B Streptococcus.

Hellerup, Denmark
October 2023
$57.4M
Venture - Series Unknown

Founder Contacts

19,000+ verified contacts

Artificial Intelligence (AI)BiotechnologyLife ScienceMedicalTherapeutics

Evozyne is a generative AI company that focuses on therapeutic discovery and drug development.

Chicago, United States
September 2023
$81.0M
Series B

Founder Contacts

19,000+ verified contacts

BiotechnologyPharmaceuticalTherapeutics

Corteria Pharmaceuticals develops first-in-class drugs in heart failure subpopulations.

Paris, France
September 2023
$69.5M
Series A

Founder Contacts

19,000+ verified contacts

Artificial Intelligence (AI)BiotechnologyLife Science

CHARM Therapeutics uses deep learning on 3D molecular configurations to develop molecule therapeutics to target pathogenic proteins.

London, United Kingdom
April 2023
$20.0M
Venture - Series Unknown

Founder Contacts

19,000+ verified contacts

BiotechnologyData Collection and LabelingHealth CareMedical DeviceWearables

Biobeat is a med-tech company that develops remote patient monitoring and data collection tool.

Boca Raton, United States
December 2025
$50.0M
Series B

Founder Contacts

19,000+ verified contacts

BiotechnologyHealth CareManufacturingTherapeutics

ProLynx is a biotechnology company that develops proprietary drug-delivery technologies to extend the half-life of therapeutic molecules.

San Francisco, United States
December 2025
$70.0M
Series A

Founder Contacts

19,000+ verified contacts

BiopharmaBiotechnologyHealth CareOncologyPharmaceuticalTherapeutics

BlossomHill Therapeutics is a biopharmaceutical company focusing on oncology and autoimmune disorders.

San Diego, United States
December 2025
$84.0M
Series B

Founder Contacts

19,000+ verified contacts

BiotechnologyLife ScienceTherapeutics

Braveheart Bio is a clinical-stage biotechnology company focused on developing precision therapies in the cardiovascular disease space.

San Francisco, United States
November 2025
$185.0M
Series A

Founder Contacts

19,000+ verified contacts

BiotechnologyMedicalNeurosciencePharmaceuticalTherapeutics

Aspen Neuroscience is a biotechnology company that specializes in personalized cell therapies and autologous regenerative medicine.

San Diego, United States
November 2025
$115.0M
Series C

Founder Contacts

19,000+ verified contacts

BiopharmaBiotechnologyPharmaceutical

Corvus Pharmaceuticals is a clinical-stage biopharmaceutical company.

Burlingame, United States
January 2026
$201.0M
Post Ipo Equity

Founder Contacts

19,000+ verified contacts

BiotechnologyHealth CareTherapeutics

AirNexis Therapeutics develops clinical-stage therapies for chronic obstructive pulmonary disease and other pulmonary conditions.

Palo Alto, United States
January 2026
$200.0M
Series A

Founder Contacts

19,000+ verified contacts

BiotechnologyHealth CareTherapeutics

BIOMx is a microbiome therapeutics company developing synbio phage therapies to eradicate harmful bacteria in chronic diseases.

Ness Ziona, Israel
December 2025
$3.0M
Post Ipo Equity

Founder Contacts

19,000+ verified contacts

BiotechnologyLife ScienceMedicalTherapeutics

Proviva Therapeutics is a pro-drug design platform for cytokines and other fusion proteins.

Shanghai, China
December 2025
$30.0M
Series A

Founder Contacts

19,000+ verified contacts

BiotechnologyPharmaceuticalTherapeutics

Invivyd develops antibodies to transcend the limitations of the human immune system and fight against viral infections.

Waltham, United States
November 2025
$125.0M
Post Ipo Equity

Founder Contacts

19,000+ verified contacts

BiopharmaBiotechnologyPharmaceutical

Verastem is a biopharmaceutical company developing new medicines to improve the lives of patients with RAS/MAPK pathway-driven cancers.

Needham, United States
November 2025
$90.0M
Post Ipo Equity

Founder Contacts

19,000+ verified contacts

BiotechnologyLife SciencePharmaceutical

TELA Bio is a life science company that specializes in soft tissue reconstruction.

Malvern, United States
November 2025
$60.0M
Post Ipo Debt

Founder Contacts

19,000+ verified contacts

BiotechnologyMedical

TandemAI is an advanced technology company dedicated to reinventing drug discovery infrastructure.

Shanghai, China
November 2025
$22.0M
Series A

Founder Contacts

19,000+ verified contacts

BiopharmaBiotechnologyHealth CareOncology

NextCure is a biopharmaceutical company focused on discovering and developing next generation immuno-oncology-based drugs.

Beltsville, United States
November 2025
$21.5M
Post Ipo Equity

Founder Contacts

19,000+ verified contacts

BiotechnologyClinical TrialsHealth CareOncologyPharmaceuticalTherapeutics

X4 Pharmaceuticals is a clinical-stage oncology company developing oral small molecule CXCR4 antagonists for the treatment.

Cambridge, United States
October 2025
$155.3M
Post Ipo Equity

Founder Contacts

19,000+ verified contacts

BiotechnologyHealth CareMedicalTherapeutics

Valneva focuses on the development and commercialization of prophylactic vaccines for infectious diseases.

Saint-herblain, France
October 2025
$215.0M
Post Ipo Debt

Founder Contacts

19,000+ verified contacts

BiopharmaBiotechnologyGeneticsPharmaceuticalTherapeutics

ReCode Therapeutics is a genetic medicines company that specializes in mRNA and gene correction therapeutics.

Dallas, United States
September 2025
$29.4M
Debt Financing

Founder Contacts

19,000+ verified contacts

BiotechnologyGeneticsHealth CareMedicalTherapeutics

Epigenic Therapeutics is a drug development company that develops gene modulation therapies through the regulation of epigenetic mechanisms.

Shanghai, China
September 2025
$60.0M
Series B

Founder Contacts

19,000+ verified contacts

BiotechnologyMedical

Congruence Therapeutics operates as a biotechnology company.

Montréal, Canada
September 2025
$32.0M
Series Unknown

Founder Contacts

19,000+ verified contacts

BiotechnologyHealth CareOncologyPharmaceutical

Apollomics is a biopharmaceutical company discovering and developing mono- and combination- oncology therapies to harness the immune system.

Foster City, United States
September 2025
$4.1M
Post Ipo Equity

Founder Contacts

19,000+ verified contacts

BiopharmaBiotechnologyMedicalPharmaceutical

Mineralys Therapeutics is a clinical-stage biopharmaceutical company committed to developing therapy for the treatment of hypertension.

Radnor, United States
September 2025
$287.5M
Post Ipo Equity

Founder Contacts

19,000+ verified contacts

BiopharmaBiotechnologyMedicalPharmaceuticalProduct ResearchTherapeutics

Minghui Pharmaceutical is a biopharmaceutical business that specializes in immunology and oncology medicines for unmet needs.

Shanghai, China
August 2025
$131.0M
Series Unknown

Founder Contacts

19,000+ verified contacts

BiotechnologyPharmaceuticalTherapeutics

Rhythm is a biopharmaceutical company focused on developing and commercializing peptide therapeutics

Boston, United States
July 2025
$175.0M
Post Ipo Equity

Founder Contacts

19,000+ verified contacts

BiotechnologyLife ScienceTherapeutics

Renasant Bio is a biopharmaceutical company pioneering disease-modifying oral small molecule treatments.

Berkeley, United States
July 2025
$54.5M
Seed

Founder Contacts

19,000+ verified contacts

BiotechnologyHealth CareLife SciencePharmaceutical

Forte Biosciences is a biotechnology company that focuses on dermatology.

Sherman Oaks, United States
June 2025
$75.0M
Post Ipo Equity

Founder Contacts

19,000+ verified contacts

BiotechnologyPharmaceuticalTherapeutics

Sirius Therapeutics is an innovative biotechnology company that focuses on RNAi therapies for cardiovascular diseases.

San Diego, United States
May 2025
$50.0M
Series B

Founder Contacts

19,000+ verified contacts

BiopharmaBiotechnologyHealth CareMedical

Lomond Therapeutics creates pharmacological platforms that target escape mutations.

San Diego, United States
March 2025
$20.0M
Series Unknown

Founder Contacts

19,000+ verified contacts

BiopharmaBiotechnologyHealth CareMedical

Curevo is a clinical-stage biotechnology company developing next-generation, non-mRNA vaccines for infectious diseases.

Bothell, United States
March 2025
$110.0M
Series B

Founder Contacts

19,000+ verified contacts

BiotechnologyHealth CareLife ScienceTherapeutics

Stratus Therapeutics develops off-the-shelf hematopoietic stem cell therapies to treat severe and life-threatening diseases.

Cambridge, United States
March 2025
$50.0M
Series A

Founder Contacts

19,000+ verified contacts

BiopharmaBiotechnologyPharmaceutical

89bio is a biopharmaceutical company that develops clinical-stage therapies for liver and cardiometabolic diseases.

San Francisco, United States
January 2025
$287.5M
Post Ipo Equity

Founder Contacts

19,000+ verified contacts

BiotechnologyHealth CareLife Science

Third Harmonic Bio is a clinical-stage company developing a first-in-class, highly selective, and oral kit inhibitor.

Cambridge, United States
January 2025
$3.9M
Post Ipo Equity

Founder Contacts

19,000+ verified contacts

BiotechnologyHealth CareMedical DeviceTherapeutics

Aerin Medical is a health technology company that develops therapeutic devices to improve nasal breathing.

Mountain View, United States
January 2025
$32.5M
Undisclosed

Founder Contacts

19,000+ verified contacts

BiotechnologyHealth CareMedical

Verdiva Bio creates cutting-edge treatments that improve results for patients with obesity and cardiometabolic diseases.

London, United Kingdom
January 2025
$411.0M
Series A

Founder Contacts

19,000+ verified contacts

BiotechnologyHealth CarePharmaceutical

Ottimo Pharma develops innovative cancer therapies using PD1-VEGFR2 antibodies.

Sandwich, United Kingdom
December 2024
$140.0M
Series A

Founder Contacts

19,000+ verified contacts

BiotechnologyHealth DiagnosticsMedicalTherapeutics

SiteOne Therapeutics develops groundbreaking non-opioid treatments for acute, neuropathic, visceral, and musculoskeletal pain.

South San Francisco, United States
December 2024
$100.0M
Series C

Founder Contacts

19,000+ verified contacts

BiotechnologyHealth DiagnosticsPharmaceuticalTherapeutics

Janux Therapeutics develops immunotherapies that generates immune responses to prevent tumors and not affecting a patient’s healthy tissue.

La Jolla, United States
December 2024
$350.0M
Post Ipo Equity

Founder Contacts

19,000+ verified contacts

BiotechnologyHealth Care

ADCendo ApS is a biotech company dedicated to developing new types of anti-cancer drugs.

Copenhagen, Denmark
November 2024
$135.0M
Series B

Founder Contacts

19,000+ verified contacts

BiotechnologyTherapeutics

Avalo Therapeutics is a clinical-stage biopharmaceutical company.

Rockville, United States
November 2024
$69.4M
Post Ipo Equity

Founder Contacts

19,000+ verified contacts

BiopharmaBiotechnologyHealth Care

Harmony Biosciences is a pharmaceutical company that develops and commercializes novel therapies for rare neurological disorders.

Plymouth Meeting, United States
October 2024
$248.0M
Post Ipo Secondary

Founder Contacts

19,000+ verified contacts

BiopharmaBiotechnologyTherapeutics

Pathalys is a clinical biopharmaceutical company that develops therapeutics that improve late-stage chronic kidney disease.

Raleigh, United States
August 2024
$105.0M
Series B

Founder Contacts

19,000+ verified contacts

BiotechnologyHealth CareMedicalPharmaceutical

ScPharmaceuticals is a biopharmaceutical company developing a portfolio of transformative pharmaceutical products for subcutaneous delivery.

Lexington, United States
August 2024
$125.0M
Post Ipo Debt

Founder Contacts

19,000+ verified contacts

BiotechnologyHealth CarePharmaceutical

Chemomab is a clinical-stage biotech company focusing on the discovery and development of innovative therapeutics.

Tel Aviv, Israel
July 2024
$10.0M
Post Ipo Equity

Founder Contacts

19,000+ verified contacts

BiotechnologyHealth CareLife ScienceNeuroscienceTherapeutics

Vigil Neuroscience is a biotechnology company that develops novel therapeutics for neurodegenerative diseases.

Cambridge, United States
June 2024
$40.0M
Post Ipo Equity

Founder Contacts

19,000+ verified contacts

BiotechnologyInformation TechnologyTechnical Support

Exsilio develops genomic therapeutics that introduce therapeutic genes into safe shelters within the DNA.

Boston, United States
June 2024
$82.0M
Series A

Founder Contacts

19,000+ verified contacts

BiopharmaBiotechnologyMedical DeviceOncology

Cullinan Therapeutics is a developer of an externally sourced cancer therapeutics used to end a drug program quickly.

Cambridge, United States
April 2024
$280.0M
Post Ipo Equity

Founder Contacts

19,000+ verified contacts

Explore OrbiMed's Full Portfolio

View all companies funded by OrbiMed across every industry and funding stage.

View Full OrbiMed Portfolio